IP Library Granted Patent US 9,090,612
Granted Patent B2
US 9,090,612 · App. 14/267,759 · Granted Jul 28, 2015

Compounds that modulate intracellular calcium

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,090,612
App. No.
14/267,759
Granted
Jul 28, 2015
Kind
B2
Abstract

Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of store-operated calcium (SOC) channels. Also described herein are methods of using such SOC channel modulators, alone and in combination with other compounds, for treating diseases or conditions that would benefit from inhibition of SOC channel activity.

Claims (25)

1. A method for treating an autoimmune disease or inflammatory disease in a mammal comprising administering to the mammal a compound having the structure of Formula (III):

wherein:

R″ 1 is

L 2 is —NH—C(═O)—, or —C(═O)NH—;

R 2 is phenyl or pyridyl; wherein phenyl or pyridyl is optionally substituted with at least one R 3 ;

R 3 is independently selected from F, Cl, Br, I, —CN, —NO 2 , —OH, —OCF 3 , —OR 5 , and —N(R 5 ) 2 ;

n is an integer selected from 1-4;

each R 5 is independently selected from C 1 -C 6 alkyl, and C 1 -C 6 haloalkyl;

R 7 is C 1 -C 6 alkyl; and

R 6 is selected from F, Cl, Br, I, —CN, —NO 2 , —OH, —CF 3 , —OCF 3 , —OR 5 , C 1 -C 6 alkyl, C 3 -C 8 cycloalkyl, and C 1 -C 6 haloalkyl;

or a pharmaceutically acceptable salt or pharmaceutically acceptable solvate thereof.

2. The method of claim 1 having the structure of Formula (IIIA):

3. The method of claim 2 wherein L 2 is —NH—C(═O)—.

4. The method of claim 3 wherein R 2 is phenyl.

5. The method of claim 4 wherein the phenyl group is substituted with at least one R 3 selected from F, Cl, Br, I, —CN, —OH, —OCF 3 , —OR 5 , and —N(R 5 ) 2 .

6. The method of claim 5 wherein R 6 is selected from —CF 3 , —OCF 3 , —OR 5 , C 1 -C 6 alkyl, and C 3 -C 8 cycloalkyl.

7. The method of claim 6 wherein R 6 is —CF 3 and R 7 is —CH 3 .

8. The method of claim 6 wherein R 6 is —CF 3 and R 7 is —CH 2 CH 3 .

9. The method of claim 5 wherein n is 1.

10. The method of claim 9 wherein R 3 is fluorine.

11. The method of claim 5 wherein phenyl is substituted with at least 2 F substituents.

12. The method of claim 5 wherein phenyl is substituted with at least 3 F substituents.

13. The method of claim 3 wherein R 2 is pyridyl.

14. The method of claim 13 wherein pyridyl is substituted with at least one R 3 selected from F, Cl, Br, —OH, —CN, —OCF 3 , —OR 5 , and —N(R 5 ) 2 .

15. The method of claim 14 wherein pyridyl is substituted with at least one fluorine.

Assignments (2)
SECURITY INTEREST Recorded Mar 4, 2025
From: CALCIMEDICA, INC.
To: AVENUE CAPITAL MANAGEMENT II, L.P.
Reel/Frame 070394/0314 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 16, 2014
From: WHITTEN, JEFFREY P.; PEI, YAZHONG; CAO, JIANGUO; WANG, ZHIJUN; ROGERS, EVAN; DYCK, BRIAN; GREY, JONATHAN
To: CALCIMEDICA, INC.
Reel/Frame 033965/0948 →